Cheng H M, Kwong K K, Xiong J, Woods B T
Howe Laboratory of Ophthalmology, Harvard Medical School, Boston, MA.
Graefes Arch Clin Exp Ophthalmol. 1992;230(1):62-5. doi: 10.1007/BF00166764.
Water enriched with the stable isotope 17O (H2(17)O) shortens the transverse relaxation time (T2) of protons in water and can therefore be used as the contrast agent for proton magnetic resonance (MR) imaging. This agent can be given topically or intravenously to demonstrate water movement in the eye. Topical H2(17)O (0.05-0.1 ml/eye, 10% enrichment) entered the anterior chamber within 5 min and dissipated from the chamber in a single-exponential fashion (flow-rate constant k = 0.1 min-1), principally due to an exchange with the iridic circulation. No H2(17)O was detected in the vitreous. Intravenous administration of H2(17)O (1 ml/kg, 10% enrichment) resulted in rapid entry (less than 20 min) of the agent into the aqueous chamber. Again, no H2(17)O was detected in the vitreous. The lens region, on the other hand, showed an increase in image intensity with time that reached a plateau after 40 min. Although these findings are preliminary, acetazolamide (20 mg/kg injected intravenously) appeared to affect iridic circulation, possibly through vasoconstriction. Potential application of this H2(17)O-enhanced MR imaging technique is discussed.
富含稳定同位素(^{17}O)的水((H_2^{17}O))可缩短水中质子的横向弛豫时间((T_2)),因此可作为质子磁共振(MR)成像的造影剂。这种造影剂可局部或静脉给药,以显示眼内的水流动情况。局部应用(H_2^{17}O)((0.05 - 0.1)毫升/眼,富集度(10%))在(5)分钟内进入前房,并以单指数方式从前房中消散(流速常数(k = 0.1)分钟(^{-1})),主要是由于与虹膜循环的交换。玻璃体中未检测到(H_2^{17}O)。静脉注射(H_2^{17}O)((1)毫升/千克,富集度(10%))导致造影剂迅速进入(不到(20)分钟)房水腔。同样,玻璃体中未检测到(H_2^{17}O)。另一方面,晶状体区域的图像强度随时间增加,(40)分钟后达到平台期。尽管这些发现是初步的,但乙酰唑胺(静脉注射(20)毫克/千克)似乎影响虹膜循环,可能是通过血管收缩。本文讨论了这种(H_2^{17}O)增强磁共振成像技术的潜在应用。